TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotec Pharmacon ASA
Closing information (x1000 SEK)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover | 89,280 | 74,599 | 72,828 |
Financial expenses | 858 | 0 | 696 |
Earnings before taxes | -6,269 | -14,166 | -24,827 |
Total assets | 82,100 | 69,680 | 61,743 |
Current assets | 61,981 | 57,234 | 50,015 |
Current liabilities | 19,431 | 14,463 | 16,886 |
Equity capital | 49,166 | 55,217 | 44,856 |
- share capital | 51,133 | 49,518 | 43,987 |
Employees (average) | 38 | 43 | 44 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency | 59.9% | 79.2% | 72.6% |
Turnover per employee | 2,349 | 1,735 | 1,655 |
Profit as a percentage of turnover | -7.0% | -19.0% | -34.1% |
Return on assets (ROA) | -6.6% | -20.3% | -39.1% |
Current ratio | 319.0% | 395.7% | 296.2% |
Return on equity (ROE) | -12.8% | -25.7% | -55.3% |
Change turnover | 12,248 | 60 | -5,854 |
Change turnover % | 16% | 0% | -7% |
Chg. No. of employees | -5 | -1 | -2 |
Chg. No. of employees % | -12% | -2% | -4% |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.